Abstract
Intra-tumoral heterogeneity is maintained by cancer stem cells (CSCs) with dysregulated self-renewal and asymmetric cell division (ACD). According to the cancer stem cell theory, by ACD a CSC can generate two daughter progenies with different fates such as one cancer stem cell and one differentiated cell. Therefore, this type of mitotic division supports vital process of the maintenance of CSC population. But this CSC pool reservation by ACD complicates the treatment of cancer patients, as CSCs give rise to aggressive clones which are prone to metastasis and drug-insensitivity. Hence, identification of therapeutic modalities which can target ACD of cancer stem cell is an intriguing part of cancer research. In this review, other than the discussion about the extrinsic inducers of ACD role of different proteins, miRNAs and lncRNAs in this type of cell division is also mentioned. Other than these, mode of action of the proven and potential drugs targeting ACD of CSC is also discussed here.
Graphical Abstract
Similar content being viewed by others
Data Availability
Not applicable.
References
Buczacki, S., Davies, R. J., & Winton, D. J. (2011). Stem cells, quiescence and rectal carcinoma: An unexplored relationship and potential therapeutic target. British Journal of Cancer, 105(9), 1253–1259. https://doi.org/10.1038/bjc.2011.362
Aponte, P. M., & Caicedo, A. (2017). Stemness in cancer: Stem cells, cancer stem cells, and their microenvironment. Stem Cells International, 2017, e5619472. https://doi.org/10.1155/2017/5619472
Knoblich, J. A. (2010). Asymmetric cell division: Recent developments and their implications for tumour biology. Nature Reviews. Molecular Cell Biology, 11(12), 849–860. https://doi.org/10.1038/nrm3010
Rasin, M.-R., Gazula, V.-R., Breunig, J. J., Kwan, K. Y., Johnson, M. B., Liu-Chen, S., …, & Sestan, N. (2007). Numb and Numbl are required for maintenance of cadherin-based adhesion and polarity of neural progenitors. Nature Neuroscience, 10(7), 819–827. https://doi.org/10.1038/nn1924
Lark, K. G., Consigli, R. A., & Minocha, H. C. (1966). Segregation of Sister Chromatids in Mammalian Cells. Science, 154(3753), 1202–1205. https://doi.org/10.1126/science.154.3753.1202
Cairns, J. (1975). Mutation selection and the natural history of cancer. Nature, 255(5505), 197–200. https://doi.org/10.1038/255197a0
Karpowicz, P., Morshead, C., Kam, A., Jervis, E., Ramunas, J., Cheng, V., & van der Kooy, D. (2005). Support for the immortal strand hypothesis: Neural stem cells partition DNA asymmetrically in vitro. Journal of Cell Biology, 170(5), 721–732. https://doi.org/10.1083/jcb.200502073
Kusch, J., Liakopoulos, D., & Barral, Y. (2003). Spindle asymmetry: A compass for the cell. Trends in Cell Biology, 13(11), 562–569. https://doi.org/10.1016/j.tcb.2003.09.008
Higgins, C. D., & Goldstein, B. (2010). Asymmetric cell division: A new way to divide unequally. Current Biology, 20(23), R1029–R1031. https://doi.org/10.1016/j.cub.2010.10.051
Sugiarto, S., Persson, A. I., Munoz, E. G., Waldhuber, M., Lamagna, C., Andor, N., …, & Petritsch, C. (2011). Asymmetry-defective oligodendrocyte progenitors are glioma precursors. Cancer Cell, 20(3), 328–340. https://doi.org/10.1016/j.ccr.2011.08.011
Cicalese, A., Bonizzi, G., Pasi, C. E., Faretta, M., Ronzoni, S., Giulini, B., …, & Pelicci, P. G. (2009). The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell, 138(6), 1083–1095. https://doi.org/10.1016/j.cell.2009.06.048
Dey-Guha, I., Wolfer, A., Yeh, A. C., J. G. Albeck, Darp, R., Leon, E., …, & Ramaswamy, S. (2011). Asymmetric cancer cell division regulated by AKT. Proceedings of the National Academy of Sciences of the United States of America, 108(31), 12845–12850. https://doi.org/10.1073/pnas.1109632108
Lathia, J. D., Hitomi, M., Gallagher, J., Gadani, S. P., Adkins, J., Vasanji, A., …, & Rich, J. N. (2011). Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death & Disease, 2, e200. https://doi.org/10.1038/cddis.2011.80
O’Brien, C. A., Kreso, A., Ryan, P., Hermans, K. G., Gibson, L., Wang, Y., …, & Dick, J. E. (2012). ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell, 21(6), 777–792. https://doi.org/10.1016/j.ccr.2012.04.036
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., …, & Di Fiore, P. P. (2010). Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell, 140(1), 62–73. https://doi.org/10.1016/j.cell.2009.12.007
Pine, S. R., Ryan, B. M., Varticovski, L., Robles, A. I., & Harris, C. C. (2010). Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 107(5), 2195–2200. https://doi.org/10.1073/pnas.0909390107
Bu, P., Chen, K.-Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., …, & Shen, X. (2013). A microRNA miR-34a regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell, 12(5), 602–615. https://doi.org/10.1016/j.stem.2013.03.002
Qu, Y., Gharbi, N., Yuan, X., Olsen, J. R., Blicher, P., Dalhus, B., …, & Ke, X. (2016). Axitinib blocks Wnt/β-catenin signaling and directs asymmetric cell division in cancer. Proceedings of the National Academy of Sciences, 113(33), 9339–9344. https://doi.org/10.1073/pnas.1604520113
Goulas, S., Conder, R., & Knoblich, J. A. (2012). The par complex and integrins direct asymmetric cell division in adult intestinal stem cells. Cell Stem Cell, 11(4), 529–540. https://doi.org/10.1016/j.stem.2012.06.017
Mukherjee, S., Kong, J., & Brat, D. J. (2015). Cancer stem cell division: When the rules of asymmetry are broken. Stem Cells and Development, 24(4), 405–416. https://doi.org/10.1089/scd.2014.0442
Mohan, A., Raj R., R., Mohan, G., K. P., P., & Maliekal, T. T. (2021). Reporters of cancer stem cells as a tool for drug discovery. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.669250
Wang, Q.-Z., Lu, Y.-H., Jiang, N., Diao, Y., & Xu, R.-A. (2010). The asymmetric division and tumorigenesis of stem cells. Chinese Journal of Cancer, 29(3), 248–253. https://doi.org/10.5732/cjc.009.10668
Peitzsch, C., Tyutyunnykova, A., Pantel, K., & Dubrovska, A. (2017). Cancer stem cells: The root of tumor recurrence and metastases. Seminars in Cancer Biology, 44, 10–24. https://doi.org/10.1016/j.semcancer.2017.02.011
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., …, & Kwon, H. Y. (2018). Cancer Stem Cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells International, 2018, 1–16. https://doi.org/10.1155/2018/5416923
Hitomi, M., Chumakova, A. P., Silver, D. J., Knudsen, A. M., Pontius, W. D., Murphy, S., …, & Lathia, J. D. (2021). Asymmetric cell division promotes therapeutic resistance in glioblastoma stem cells. JCI Insight, 6(3). https://doi.org/10.1172/jci.insight.130510
Chen, W., Dong, J., Haiech, J., Kilhoffer, M.-C., & Zeniou, M. (2016). Cancer stem cell quiescence and plasticity as major challenges in cancer therapy. Stem Cells International, 2016, 1–16. https://doi.org/10.1155/2016/1740936
Tomasetti, C., & Levy, D. (2010). Role of symmetric and asymmetric division of stem cells in developing drug resistance. Proceedings of the National Academy of Sciences, 107(39), 16766–16771. https://doi.org/10.1073/pnas.1007726107
Iwasa, Y., Nowak, M. A., & Michor, F. (2006). Evolution of resistance during clonal expansion. Genetics, 172(4), 2557–2566. https://doi.org/10.1534/genetics.105.049791
Plaks, V., Kong, N., & Werb, Z. (2015). The cancer stem cell niche: How essential is the niche in regulating stemness of tumor cells? Cell Stem Cell, 16(3), 225–238. https://doi.org/10.1016/j.stem.2015.02.015
Zahan, T., Das, P. K., Akter, S. F., Habib, R., Rahman, Md. H., Karim, Md. R., & Islam, F. (2020). Therapy resistance in cancers: Phenotypic, metabolic, epigenetic and tumour microenvironmental perspectives. Anti-Cancer Agents in Medicinal Chemistry, 20(18), 2190–2206. https://doi.org/10.2174/1871520620999200730161829
Kunisaki, Y., Bruns, I., Scheiermann, C., Ahmed, J., Pinho, S., Zhang, D., …, & Frenette, P. S. (2013). Arteriolar niches maintain haematopoietic stem cell quiescence. Nature, 502(7473), 637–643. https://doi.org/10.1038/nature12612
Kiel, M. J., Yilmaz, O. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005). SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 121(7), 1109–1121. https://doi.org/10.1016/j.cell.2005.05.026
Snippert, H. J., van der Flier, L. G., Sato, T., van Es, J. H., van den Born, M., Kroon-Veenboer, C., …, & Clevers, H. (2010). Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell, 143(1), 134–144. https://doi.org/10.1016/j.cell.2010.09.016
Lopez-Garcia, C., Klein, A. M., Simons, B. D., & Winton, D. J. (2010). Intestinal stem cell replacement follows a pattern of neutral drift. Science (New York, N.Y.), 330(6005), 822–825. https://doi.org/10.1126/science.1196236
Albini, A., Bruno, A., Gallo, C., Pajardi, G., Noonan, D. M., & Dallaglio, K. (2015). Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity. Connective Tissue Research, 56(5), 414–425. https://doi.org/10.3109/03008207.2015.1066780
Cancer Stem Cells and the Tumor Microenvironment: Soloists or Choral Singers | Bentham Science. (n.d.). Retrieved November 16, 2022, from https://www.eurekaselect.com/article/13659
Albini, A., Cesana, E., & Noonan, D. M. (2011). Cancer stem cells and the tumor microenvironment: Soloists or choral singers. Current Pharmaceutical Biotechnology, 12(2), 171–181. https://doi.org/10.2174/138920111794295756
Siegrist, S. E., & Doe, C. Q. (2006). Extrinsic cues orient the cell division axis in Drosophila embryonic neuroblasts. Development (Cambridge, England), 133(3), 529–536. https://doi.org/10.1242/dev.02211
Barui, A., & Datta, P. (2019). Biophysical factors in the regulation of asymmetric division of stem cells. Biological Reviews, 94(3), 810–827. https://doi.org/10.1111/brv.12479
Lagadec, C., Vlashi, E., Alhiyari, Y., Phillips, T. M., Bochkur Dratver, M., & Pajonk, F. (2013). Radiation-induced notch signaling in breast cancer stem cells. International Journal of Radiation Oncology*Biology*Physics, 87(3), 609–618. https://doi.org/10.1016/j.ijrobp.2013.06.2064
Tomasetti, C., & Vogelstein, B. (2017). On the slope of the regression between stem cell divisions and cancer risk, and the lack of correlation between stem cell divisions and environmental factors-associated cancer risk. PLOS ONE, 12(5), e0175535. https://doi.org/10.1371/journal.pone.0175535
Wu, S., Powers, S., Zhu, W., & Hannun, Y. A. (2016). Substantial contribution of extrinsic risk factors to cancer development. Nature, 529(7584), 43–47. https://doi.org/10.1038/nature16166
Analysing differences between scenarios - ScienceDirect. (n.d.). Retrieved November 16, 2022, from https://www.sciencedirect.com/science/article/pii/S0169207022000346?via%3Dihub
Pajonk, F., Vlashi, E., & McBride, W. H. (2010). Radiation resistance of cancer stem cells: The 4 R’s of radiobiology revisited. Stem Cells, 28(4), 639–648. https://doi.org/10.1002/stem.318
Umar, S. (2010). Intestinal stem cells. Current Gastroenterology Reports, 12(5), 340–348. https://doi.org/10.1007/s11894-010-0130-3
Grün, A., Kuhnt, T., Schlomm, T., Olze, H., Budach, V., & Stromberger, C. (2020). Repeat radiation for local recurrence of head and neck tumors and in prostate cancer. Deutsches Ärzteblatt International, 117(10), 167–174. https://doi.org/10.3238/arztebl.2020.0167
Withers, H. R., Maciejewski, B., Taylor, J. M., & Hliniak, A. (1988). Accelerated repopulation in head and neck cancer. Frontiers of Radiation Therapy and Oncology, 22, 105–110. https://doi.org/10.1159/000415101
Campa, V. M., Gutiérrez-Lanza, R., Cerignoli, F., Díaz-Trelles, R., Nelson, B., Tsuji, T., …, & Mercola, M. (2008). Notch activates cell cycle reentry and progression in quiescent cardiomyocytes. The Journal of Cell Biology, 183(1), 129–141. https://doi.org/10.1083/jcb.200806104
Phillips, T. M., McBride, W. H., & Pajonk, F. (2006). The Response of CD24 −/low /CD44 + Breast Cancer–Initiating Cells to Radiation. JNCI: Journal of the National Cancer Institute, 98(24), 1777–1785. https://doi.org/10.1093/jnci/djj495
Srinivasan, T., Walters, J., Bu, P., Than, E. B., Tung, K.-L., Chen, K.-Y., …, & Shen, X. (2016). NOTCH signaling regulates asymmetric cell fate of fast- and slow-cycling colon cancer–initiating cells. Cancer Research, 76(11), 3411–3421. https://doi.org/10.1158/0008-5472.CAN-15-3198
Ehrhart, E. J., Segarini, P., Tsang, M.L.-S., Carroll, A. G., & Barcellos-Hoff, M. H. (1997). Latent transforming growth factor β1 activation in situ: Quantitative and functional evidence after low-dose γ-irradiation 1. The FASEB Journal, 11(12), 991–1002. https://doi.org/10.1096/fasebj.11.12.9337152
Najafi, M., Farhood, B., Mortezaee, K., Kharazinejad, E., Majidpoor, J., & Ahadi, R. (2020). Hypoxia in solid tumors: A key promoter of cancer stem cell (CSC) resistance. Journal of Cancer Research and Clinical Oncology, 146(1), 19–31. https://doi.org/10.1007/s00432-019-03080-1
de Almeida Rainho, M., Mencalha, A. L., & Thole, A. A. (2021). Hypoxia effects on cancer stem cell phenotype in colorectal cancer: A mini-review. Molecular Biology Reports, 48(11), 7527–7535. https://doi.org/10.1007/s11033-021-06809-9
Liu, W., Wen, Y., Bi, P., Lai, X., Liu, X. S., Liu, X., & Kuang, S. (2012). Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation. Development (Cambridge, England), 139(16), 2857–2865. https://doi.org/10.1242/dev.079665
Khan, W. S., Adesida, A. B., & Hardingham, T. E. (2007). Hypoxic conditions increase hypoxia-inducible transcription factor 2α and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients. Arthritis Research & Therapy, 9(3), R55. https://doi.org/10.1186/ar2211
Shang, J., Liu, H., Li, J., & Zhou, Y. (2014). Roles of hypoxia during the chondrogenic differentiation of mesenchymal stem cells. Current Stem Cell Research & Therapy, 9(2), 141–147. https://doi.org/10.2174/1574888x09666131230142459
Hurt, E. M., Kawasaki, B. T., Klarmann, G. J., Thomas, S. B., & Farrar, W. L. (2008). CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. British Journal of Cancer, 98(4), 756–765. https://doi.org/10.1038/sj.bjc.6604242
Yao, L., Pandit, A., Yao, S., & McCaig, C. D. (2011). Electric field-guided neuron migration: A novel approach in neurogenesis. Tissue Engineering Part B: Reviews, 17(3), 143–153. https://doi.org/10.1089/ten.teb.2010.0561
Funk, R. H. W. (2015). Endogenous electric fields as guiding cue for cell migration. Frontiers in Physiology, 6. https://doi.org/10.3389/fphys.2015.00143
McMurray, R. J., Gadegaard, N., Tsimbouri, P. M., Burgess, K. V., McNamara, L. E., Tare, R., …, & Dalby, M. J. (2011). Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nature Materials, 10(8), 637–644. https://doi.org/10.1038/nmat3058
Chen, Y.-A., Lu, C.-Y., Cheng, T.-Y., Pan, S.-H., Chen, H.-F., & Chang, N.-S. (2019). WW domain-containing proteins YAP and TAZ in the hippo pathway as key regulators in stemness maintenance, tissue homeostasis, and tumorigenesis. Frontiers in Oncology, 9, 60. https://doi.org/10.3389/fonc.2019.00060
Elbediwy, A., Vincent-Mistiaen, Z. I., & Thompson, B. J. (2016). YAP and TAZ in epithelial stem cells: A sensor for cell polarity, mechanical forces and tissue damage. BioEssays, 38(7), 644–653. https://doi.org/10.1002/bies.201600037
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014). The biology of YAP/TAZ: Hippo signaling and beyond. Physiological Reviews, 94(4), 1287–1312. https://doi.org/10.1152/physrev.00005.2014
Lam, A. K., & Phillips, B. T. (2017). Wnt Signaling Polarizes C. elegans Asymmetric Cell Divisions During Development. In J.-P. Tassan & J. Z. Kubiak (Eds.), Asymmetric Cell Division in Development, Differentiation and Cancer (vol. 61, pp. 83–114). Springer International Publishing. https://doi.org/10.1007/978-3-319-53150-2_4
Egger, B., Gold, K. S., & Brand, A. H. (2011). Regulating the balance between symmetric and asymmetric stem cell division in the developing brain. Fly, 5(3), 237–241. https://doi.org/10.4161/fly.5.3.15640
Drug resistance mechanisms of cancer stem-like cells and their therapeutic potential as drug targets. (n.d.). Retrieved November 16, 2022, from https://cdrjournal.com/article/view/3153
Kopan, R. (2012). Notch signaling. Cold Spring Harbor Perspectives in Biology, 4(10), a011213–a011213. https://doi.org/10.1101/cshperspect.a011213
Lobry, C., Oh, P., & Aifantis, I. (2011). Oncogenic and tumor suppressor functions of Notch in cancer: It’s NOTCH what you think. Journal of Experimental Medicine, 208(10), 1931–1935. https://doi.org/10.1084/jem.20111855
Katoh, M., & Katoh, M. (2007). Notch signaling in gastrointestinal tract (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.30.1.247
Leong, K. G., & Karsan, A. (2006). Recent insights into the role of Notch signaling in tumorigenesis. Blood, 107(6), 2223–2233. https://doi.org/10.1182/blood-2005-08-3329
Liu, Z.-H., Dai, X.-M., & Du, B. (2015). Hes1: A key role in stemness, metastasis and multidrug resistance. Cancer Biology & Therapy, 16(3), 353–359. https://doi.org/10.1080/15384047.2015.1016662
Flores, A. N., McDermott, N., Meunier, A., & Marignol, L. (2014). NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer. Nature Reviews Urology, 11(9), 499–507. https://doi.org/10.1038/nrurol.2014.195
Sang, L., Roberts, J. M., & Coller, H. A. (2010). Hijacking HES1: How tumors co-opt the anti-differentiation strategies of quiescent cells. Trends in Molecular Medicine, 16(1), 17–26. https://doi.org/10.1016/j.molmed.2009.11.001
Nakamura, Y., Sakakibara, S., Miyata, T., Ogawa, M., Shimazaki, T., Weiss, S., …, & Okano, H. (2000). The bHLH Gene Hes1 as a repressor of the neuronal commitment of CNS stem cells. The Journal of Neuroscience, 20(1), 283–293. https://doi.org/10.1523/JNEUROSCI.20-01-00283.2000
Yang, L., Tang, H., Kong, Y., Xie, X., Chen, J., Song, C., …, & Xie, X. (2015). LGR5 promotes breast cancer progression and maintains stem-like cells through activation of Wnt/β-catenin signaling. Stem Cells, 33(10), 2913–2924. https://doi.org/10.1002/stem.2083
Fan, C., He, L., Kapoor, A., Rybak, A. P., De Melo, J., Cutz, J.-C., & Tang, D. (2009). PTEN inhibits BMI1 function independently of its phosphatase activity. Molecular Cancer, 8(1), 98. https://doi.org/10.1186/1476-4598-8-98
Choi, H. Y., Seok, J., Kang, G.-H., Lim, K. M., & Cho, S.-G. (2021). The role of NUMB/NUMB isoforms in cancer stem cells. BMB Reports, 54(7), 335–343. https://doi.org/10.5483/BMBRep.2021.54.7.048
Habib, S. J., Chen, B.-C., Tsai, F.-C., Anastassiadis, K., Meyer, T., Betzig, E., & Nusse, R. (2013). A localized Wnt signal orients asymmetric stem cell division in vitro. Science, 339(6126), 1445–1448. https://doi.org/10.1126/science.1231077
Reya, T., & Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature, 434(7035), 843–850. https://doi.org/10.1038/nature03319
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., & Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nature Medicine, 10(1), 55–63. https://doi.org/10.1038/nm979
Davidson, K. C., Adams, A. M., Goodson, J. M., McDonald, C. E., Potter, J. C., Berndt, J. D., …, & Moon, R. T. (2012). Wnt/β-catenin signaling promotes differentiation, not self-renewal, of human embryonic stem cells and is repressed by Oct4. Proceedings of the National Academy of Sciences, 109(12), 4485–4490. https://doi.org/10.1073/pnas.1118777109
Zhang, K., Guo, Y., Wang, X., Zhao, H., Ji, Z., Cheng, C., …, & Gao, W.-Q. (2017). WNT/β-catenin directs self-renewal symmetric cell division of hTERThigh Prostate cancer stem cells. Cancer Research, 77(9), 2534–2547. https://doi.org/10.1158/0008-5472.CAN-16-1887
Boyd, L., Guo, S., Levitan, D., Stinchcomb, D. T., & Kemphues, K. J. (1996). PAR-2 is asymmetrically distributed and promotes association of P granules and PAR-1 with the cortex in C. elegans embryos. Development, 122(10), 3075–3084. https://doi.org/10.1242/dev.122.10.3075
Guo, S., & Kemphues, K. J. (1995). par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell, 81(4), 611–620. https://doi.org/10.1016/0092-8674(95)90082-9
Sailer, A., Anneken, A., Li, Y., Lee, S., & Munro, E. (2015). Dynamic opposition of clustered proteins stabilizes cortical polarity in the C. elegans zygote. Developmental Cell, 35(1), 131–142. https://doi.org/10.1016/j.devcel.2015.09.006
Kumfer, K. T., Cook, S. J., Squirrell, J. M., Eliceiri, K. W., Peel, N., O’Connell, K. F., & White, J. G. (2010). CGEF-1 and CHIN-1 regulate CDC-42 activity during asymmetric division in the Caenorhabditis elegans embryo. Molecular Biology of the Cell, 21(2), 266–277. https://doi.org/10.1091/mbc.e09-01-0060
Neumüller, R. A., & Knoblich, J. A. (2009). Dividing cellular asymmetry: Asymmetric cell division and its implications for stem cells and cancer. Genes & Development, 23(23), 2675–2699. https://doi.org/10.1101/gad.1850809
Lang, C. F., & Munro, E. (2017). The PAR proteins: From molecular circuits to dynamic self-stabilizing cell polarity. Development, 144(19), 3405–3416. https://doi.org/10.1242/dev.139063
Harris, T. J. C. (2017). Protein clustering for cell polarity: Par-3 as a paradigm. F1000Research. https://doi.org/10.12688/f1000research.11976.1
Bultje, R. S., Castaneda-Castellanos, D. R., Jan, L. Y., Jan, Y.-N., Kriegstein, A. R., & Shi, S.-H. (2009). Mammalian Par3 regulates progenitor cell asymmetric division via Notch signaling in the developing neocortex. Neuron, 63(2), 189–202. https://doi.org/10.1016/j.neuron.2009.07.004
Chen, S., Chen, J., Shi, H., Wei, M., Castaneda-Castellanos, D. R., Bultje, R. S., …, & Shi, S.-H. (2013). Regulation of microtubule stability and organization by Mammalian Par3 in specifying neuronal polarity. Developmental Cell, 24(1), 26–40. https://doi.org/10.1016/j.devcel.2012.11.014
Zhou, P.-J., Wang, X., An, N., Wei, L., Zhang, L., Huang, X., …, & Gao, W.-Q. (2019). Loss of Par3 promotes prostatic tumorigenesis by enhancing cell growth and changing cell division modes. Oncogene, 38(12), 2192–2205. https://doi.org/10.1038/s41388-018-0580-x
The Polarity Protein Par6 Induces Cell Proliferation and Is Overexpressed in Breast Cancer - PMC. (n.d.). Retrieved November 17, 2022, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948755/
Lim, Y. W., Wen, F.-L., Shankar, P., Shibata, T., & Motegi, F. (2021). A balance between antagonizing PAR proteins specifies the pattern of asymmetric and symmetric divisions in C. elegans embryogenesis. Cell Reports, 36(1), 109326. https://doi.org/10.1016/j.celrep.2021.109326
Wirtz-Peitz, F., Nishimura, T., & Knoblich, J. A. (2008). Linking cell cycle to asymmetric division: Aurora-A phosphorylates the par complex to regulate Numb localization. Cell, 135(1), 161–173. https://doi.org/10.1016/j.cell.2008.07.049
par-6, a gene involved in the establishment of asymmetry in early C. elegans embryos, mediates the asymmetric localization of PAR-3 | Development | The Company of Biologists. (n.d.). Retrieved November 17, 2022, from https://journals.biologists.com/dev/article/122/10/3133/38958/par-6-a-gene-involved-in-the-establishment-of
Suzuki, A., & Ohno, S. (2006). The PAR-aPKC system: Lessons in polarity. Journal of Cell Science, 119(6), 979–987. https://doi.org/10.1242/jcs.02898
Suzuki, A., Yamanaka, T., Hirose, T., Manabe, N., Mizuno, K., Shimizu, M., …, & Ohno, S. (2001). Atypical protein kinase C is involved in the evolutionarily conserved par protein complex and plays a critical role in establishing epithelia-specific junctional structures. The Journal of Cell Biology, 152(6), 1183–1196. https://doi.org/10.1083/jcb.152.6.1183
Macara, I. G. (2004). Parsing the polarity code. Nature Reviews Molecular Cell Biology, 5(3), 220–231. https://doi.org/10.1038/nrm1332
Atypical protein kinase C cooperates with PAR-3 to establish embryonic polarity in Caenorhabditis elegans - PubMed. (n.d.). Retrieved November 17, 2022, from https://pubmed.ncbi.nlm.nih.gov/9716526/
Prehoda, K. E. (2009). Polarization of Drosophila neuroblasts during asymmetric division. Cold Spring Harbor Perspectives in Biology, 1(2), a001388–a001388. https://doi.org/10.1101/cshperspect.a001388
Liu, J., Sato, C., Cerletti, M., & Wagers, A. (2010). Notch Signaling in the Regulation of Stem Cell Self-Renewal and Differentiation. In Current Topics in Developmental Biology (vol. 92, pp. 367–409). Elsevier. https://doi.org/10.1016/S0070-2153(10)92012-7
Bilder, D., & Perrimon, N. (2000). Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature, 403(6770), 676–680. https://doi.org/10.1038/35001108
Powell, A. E., Shung, C.-Y., Saylor, K. W., Müllendorf, K. A., Weiss, J. B., & Wong, M. H. (2010). Lessons from development: A role for asymmetric stem cell division in cancer. Stem Cell Research, 4(1), 3–9. https://doi.org/10.1016/j.scr.2009.09.005
Paglia, S., Sollazzo, M., Di Giacomo, S., de Biase, D., Pession, A., & Grifoni, D. (2017). Failure of the PTEN/aPKC/Lgl axis primes formation of adult brain tumours in Drosophila. BioMed Research International, 2017, 1–14. https://doi.org/10.1155/2017/2690187
Ohshiro, T., Yagami, T., Zhang, C., & Matsuzaki, F. (2000). Role of cortical tumour-suppressor proteins in asymmetric division of Drosophila neuroblast. Nature, 408(6812), 593–596. https://doi.org/10.1038/35046087
Khazaei, M. R., & Püschel, A. W. (2009). Phosphorylation of the par polarity complex protein Par3 at serine 962 Is mediated by Aurora A and regulates its function in neuronal polarity. Journal of Biological Chemistry, 284(48), 33571–33579. https://doi.org/10.1074/jbc.M109.055897
Rolls, M. M., Albertson, R., Shih, H.-P., Lee, C.-Y., & Doe, C. Q. (2003). Drosophila aPKC regulates cell polarity and cell proliferation in neuroblasts and epithelia. Journal of Cell Biology, 163(5), 1089–1098. https://doi.org/10.1083/jcb.200306079
Kuphal, S., Wallner, S., Schimanski, C. C., Bataille, F., Hofer, P., Strand, S., …, & Bosserhoff, A. K. (2006). Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene, 25(1), 103–110. https://doi.org/10.1038/sj.onc.1209008
Yasumi, M., Sakisaka, T., Hoshino, T., Kimura, T., Sakamoto, Y., Yamanaka, T., …, & Takai, Y. (2005). Direct Binding of Lgl2 to LGN during Mitosis and Its Requirement for Normal Cell Division. Journal of Biological Chemistry, 280(8), 6761–6765. https://doi.org/10.1074/jbc.C400440200
Liu, X., Lu, D., Ma, P., Liu, H., Cao, Y., Sang, B., …, & Zhou, X. (2015). Hugl-1 inhibits glioma cell growth in intracranial model. Journal of Neuro-Oncology, 125(1), 113–121. https://doi.org/10.1007/s11060-015-1901-3
Barros, C. S., Phelps, C. B., & Brand, A. H. (2003). Drosophila nonmuscle myosin II promotes the asymmetric segregation of cell fate determinants by cortical exclusion rather than active transport. Developmental Cell, 5(6), 829–840. https://doi.org/10.1016/s1534-5807(03)00359-9
Katayama, H., Brinkley, W. R., & Sen, S. (2003). The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Reviews, 22(4), 451–464. https://doi.org/10.1023/a:1023789416385
Nikonova, A. S., Astsaturov, I., Serebriiskii, I. G., Dunbrack, R. L., & Golemis, E. A. (2013). Aurora A kinase (AURKA) in normal and pathological cell division. Cellular and Molecular Life Sciences, 70(4), 661–687. https://doi.org/10.1007/s00018-012-1073-7
Lee, C.-Y., Andersen, R. O., Cabernard, C., Manning, L., Tran, K. D., Lanskey, M. J., …, & Doe, C. Q. (2006). Drosophila Aurora-A kinase inhibits neuroblast self-renewal by regulating aPKC/Numb cortical polarity and spindle orientation. Genes & Development, 20(24), 3464–3474. https://doi.org/10.1101/gad.1489406
Wang, H., Somers, G. W., Bashirullah, A., Heberlein, U., Yu, F., & Chia, W. (2006). Aurora-A acts as a tumor suppressor and regulates self-renewal of Drosophila neuroblasts. Genes & Development, 20(24), 3453–3463. https://doi.org/10.1101/gad.1487506
Kim, A. J., & Griffin, E. E. (2021). PLK-1 Regulation of Asymmetric Cell Division in the Early C. elegans Embryo. Frontiers in Cell and Developmental Biology, 8. https://doi.org/10.3389/fcell.2020.632253
Takaki, T., Trenz, K., Costanzo, V., & Petronczki, M. (2008). Polo-like kinase 1 reaches beyond mitosis—cytokinesis, DNA damage response, and development. Current Opinion in Cell Biology, 20(6), 650–660. https://doi.org/10.1016/j.ceb.2008.10.005
Budirahardja, Y., & Gönczy, P. (2008). PLK-1 asymmetry contributes to asynchronous cell division of C. elegans embryos. Development, 135(7), 1303–1313. https://doi.org/10.1242/dev.019075
Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon | Nature. (n.d.). Retrieved November 17, 2022, from https://www.nature.com/articles/nature06056
Rivers, D. M., Moreno, S., Abraham, M., & Ahringer, J. (2008). PAR proteins direct asymmetry of the cell cycle regulators Polo-like kinase and Cdc25. Journal of Cell Biology, 180(5), 877–885. https://doi.org/10.1083/jcb.200710018
van Vugt, M. A. T. M., van de Weerdt, B. C. M., Vader, G., Janssen, H., Calafat, J., Klompmaker, R., …, & Medema, R. H. (2004). Polo-like Kinase-1 Is Required for Bipolar Spindle Formation but Is Dispensable for Anaphase Promoting Complex/Cdc20 Activation and Initiation of Cytokinesis. Journal of Biological Chemistry, 279(35), 36841–36854. https://doi.org/10.1074/jbc.M313681200
Kulukian, A., & Fuchs, E. (2013). Spindle orientation and epidermal morphogenesis. Philosophical Transactions of the Royal Society B: Biological Sciences, 368(1629), 20130016. https://doi.org/10.1098/rstb.2013.0016
Wodarz, A., Ramrath, A., Kuchinke, U., & Knust, E. (1999). Bazooka provides an apical cue for Inscuteable localization in Drosophila neuroblasts. Nature, 402(6761), 544–547. https://doi.org/10.1038/990128
Knoblich, J. A. (2010). Asymmetric cell division: Recent developments and their implications for tumour biology. Nature Reviews Molecular Cell Biology, 11(12), 849–860. https://doi.org/10.1038/nrm3010
Willard, F. S., Kimple, R. J., & Siderovski, D. P. (2004). Return of the GDI: The GoLoco motif in cell division. Annual Review of Biochemistry, 73(1), 925–951. https://doi.org/10.1146/annurev.biochem.73.011303.073756
Wodarz, A., & Näthke, I. (2007). Cell polarity in development and cancer. Nature Cell Biology, 9(9), 1016–1024. https://doi.org/10.1038/ncb433
Chia, W., Somers, W. G., & Wang, H. (2008). Drosophila neuroblast asymmetric divisions: Cell cycle regulators, asymmetric protein localization, and tumorigenesis. Journal of Cell Biology, 180(2), 267–272. https://doi.org/10.1083/jcb.200708159
Uemura, T., Shepherd, S., Ackerman, L., Jan, L. Y., & Jan, Y. N. (1989). Numb, a gene required in determination of cell fate during sensory organ formation in Drosophila embryos. Cell, 58(2), 349–360. https://doi.org/10.1016/0092-8674(89)90849-0
Gulino, A., Di Marcotullio, L., & Screpanti, I. (2010). The multiple functions of Numb. Experimental Cell Research, 316(6), 900–906. https://doi.org/10.1016/j.yexcr.2009.11.017
Zhong, W., Feder, J. N., Jiang, M.-M., Jan, L. Y., & Jan, Y. N. (1996). Asymmetric localization of a mammalian Numb homolog during mouse cortical neurogenesis. Neuron, 17(1), 43–53. https://doi.org/10.1016/S0896-6273(00)80279-2
Petersen, P. H., Zou, K., Hwang, J. K., Jan, Y. N., & Zhong, W. (2002). Progenitor cell maintenance requires Numb and numblike during mouse neurogenesis. Nature, 419(6910), 929–934. https://doi.org/10.1038/nature01124
Berdnik, D., Török, T., González-Gaitán, M., & Knoblich, J. A. (2002). The endocytic protein α-Adaptin is required for Numb-mediated asymmetric cell division in Drosophila. Developmental Cell, 3(2), 221–231. https://doi.org/10.1016/S1534-5807(02)00215-0
Yamamoto, S., Charng, W.-L., & Bellen, H. J. (2010). Endocytosis and Intracellular Trafficking of Notch and Its Ligands. In Current Topics in Developmental Biology (vol. 92, pp. 165–200). Elsevier. https://doi.org/10.1016/S0070-2153(10)92005-X
Shao, X., Ding, Z., Zhao, M., Liu, K., Sun, H., Chen, J., …, & Li, H. (2017). Mammalian Numb protein antagonizes Notch by controlling postendocytic trafficking of the Notch ligand Delta-like 4. Journal of Biological Chemistry, 292(50), 20628–20643. https://doi.org/10.1074/jbc.M117.800946
Guo, M., Jan, L. Y., & Jan, Y. N. (1996). Control of daughter cell fates during asymmetric division: Interaction of Numb and Notch. Neuron, 17(1), 27–41. https://doi.org/10.1016/S0896-6273(00)80278-0
O’Connor-Giles, K. M., & Skeath, J. B. (2003). Numb inhibits membrane localization of Sanpodo, a Four-pass transmembrane protein, to promote asymmetric divisions in Drosophila. Developmental Cell, 5(2), 231–243. https://doi.org/10.1016/S1534-5807(03)00226-0
Frise, E., Knoblich, J. A., Younger-Shepherd, S., Jan, L. Y., & Jan, Y. N. (1996). The Drosophila Numb protein inhibits signaling of the Notch receptor during cell-cell interaction in sensory organ lineage. Proceedings of the National Academy of Sciences of the United States of America, 93(21), 11925–11932.
McGill, M. A., & McGlade, C. J. (2003). Mammalian Numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. Journal of Biological Chemistry, 278(25), 23196–23203. https://doi.org/10.1074/jbc.M302827200
Di Marcotullio, L., Greco, A., Mazzà, D., Canettieri, G., Pietrosanti, L., Infante, P., …, & Gulino, A. (2011). Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal. Oncogene, 30(1), 65–76. https://doi.org/10.1038/onc.2010.394
Tokumitsu, H., Hatano, N., Yokokura, S., Sueyoshi, Y., Nozaki, N., & Kobayashi, R. (2006). Phosphorylation of Numb regulates its interaction with the clathrin-associated adaptor AP-2. FEBS Letters, 580(24), 5797–5801. https://doi.org/10.1016/j.febslet.2006.09.043
Smith, C. A., Lau, K. M., Rahmani, Z., Dho, S. E., Brothers, G., She, Y. M., …, & McGlade, C. J. (2007). aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. The EMBO Journal, 26(2), 468–480. https://doi.org/10.1038/sj.emboj.7601495
Lu, B., Rothenberg, M., Jan, L. Y., & Jan, Y. N. (1998). Partner of Numb colocalizes with Numb during mitosis and directs Numb asymmetric localization in Drosophila neural and muscle progenitors. Cell, 95(2), 225–235. https://doi.org/10.1016/S0092-8674(00)81753-5
Giuffrida, D., & Rogers, I. M. (2010). Targeting cancer stem cell lines as a new treatment of human cancer. Recent Patents on Anti-Cancer Drug Discovery, 5(3), 205–218. https://doi.org/10.2174/157489210791760535
Zhu, K., Shan, Z., Zhang, L., & Wen, W. (2016). Phospho-pon binding-mediated fine-tuning of Plk1 activity. Structure, 24(7), 1110–1119. https://doi.org/10.1016/j.str.2016.04.012
Wang, H., Ouyang, Y., Somers, W. G., Chia, W., & Lu, B. (2007). Polo inhibits progenitor self-renewal and regulates Numb asymmetry by phosphorylating Pon. Nature, 449(7158), 96–100. https://doi.org/10.1038/nature06056
Knoblich, J. A., Jan, & Jan, Y. N. (1995). Asymmetric segregation of Numb and Prospero during cell division. Nature, 377(6550), 624–627. https://doi.org/10.1038/377624a0
Vessey, J. P., Amadei, G., Burns, S. E., Kiebler, M. A., Kaplan, D. R., & Miller, F. D. (2012). An asymmetrically localized Staufen2-dependent RNA complex regulates maintenance of mammalian neural stem cells. Cell Stem Cell, 11(4), 517–528. https://doi.org/10.1016/j.stem.2012.06.010
Wiener, Z., Högström, J., Hyvönen, V., Band, A. M., Kallio, P., Holopainen, T., …, & Alitalo, K. (2014). Prox1 promotes expansion of the colorectal cancer stem cell population to fuel tumor growth and ischemia resistance. Cell Reports, 8(6), 1943–1956. https://doi.org/10.1016/j.celrep.2014.08.034
Wu, P.-S., Egger, B., & Brand, A. H. (2008). Asymmetric stem cell division: Lessons from Drosophila. Seminars in Cell & Developmental Biology, 19(3), 283–293. https://doi.org/10.1016/j.semcdb.2008.01.007
Bajaj, J., Hamilton, M., Shima, Y., Chambers, K., Spinler, K., Van Nostrand, E. L., …, & Reya, T. (2020). An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia. Nature Cancer, 1(4), 410–422. https://doi.org/10.1038/s43018-020-0054-2
Li, P., Yang, X., Wasser, M., Cai, Y., & Chia, W. (1997). Inscuteable and staufen mediate asymmetric localization and segregation of prospero RNA during Drosophila neuroblast cell divisions. Cell, 90(3), 437–447. https://doi.org/10.1016/S0092-8674(00)80504-8
Broadus, J., Fuerstenberg, S., & Doe, C. Q. (1998). Staufen-dependent localization of prospero mRNA contributes to neuroblast daughter-cell fate. Nature, 391(6669), 792–795. https://doi.org/10.1038/35861
Gómez-López, S., Lerner, R. G., & Petritsch, C. (2014). Asymmetric cell division of stem and progenitor cells during homeostasis and cancer. Cellular and Molecular Life Sciences: CMLS, 71(4), 575–597. https://doi.org/10.1007/s00018-013-1386-1
Shen, C.-P., Jan, L. Y., & Jan, Y. N. (1997). Miranda is required for the asymmetric localization of prospero during mitosis in Drosophila. Cell, 90(3), 449–458. https://doi.org/10.1016/S0092-8674(00)80505-X
Shen, C.-P., Knoblich, J. A., Chan, Y.-M., Jiang, M.-M., Jan, L. Y., & Jan, Y. N. (1998). Miranda as a multidomain adapter linking apically localized Inscuteable and basally localized Staufen and Prospero during asymmetric cell division in Drosophila. Genes & Development, 12(12), 1837–1846.
Ikeshima-Kataoka, H., Skeath, J. B., Nabeshima, Y., Doe, C. Q., & Matsuzaki, F. (1997). Miranda directs Prospero to a daughter cell during Drosophila asymmetric divisions. Nature, 390(6660), 625–629. https://doi.org/10.1038/37641
Matsuzaki, F., Ohshiro, T., Ikeshima-Kataoka, H., & Izumi, H. (1998). miranda localizes staufen and prospero asymmetrically in mitotic neuroblasts and epithelial cells in early Drosophila embryogenesis. Development (Cambridge, England), 125(20), 4089–4098. https://doi.org/10.1242/dev.125.20.4089
Betschinger, J., Mechtler, K., & Knoblich, J. A. (2006). Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells. Cell, 124(6), 1241–1253. https://doi.org/10.1016/j.cell.2006.01.038
Lee, C.-Y., Wilkinson, B. D., Siegrist, S. E., Wharton, R. P., & Doe, C. Q. (2006). Brat is a Miranda cargo protein that promotes neuronal differentiation and inhibits neuroblast self-renewal. Developmental Cell, 10(4), 441–449. https://doi.org/10.1016/j.devcel.2006.01.017
Czerwińska, P., Mazurek, S., & Wiznerowicz, M. (2017). The complexity of TRIM28 contribution to cancer. Journal of Biomedical Science, 24(1), 63. https://doi.org/10.1186/s12929-017-0374-4
Hadjimichael, C., Chanoumidou, K., Nikolaou, C., Klonizakis, A., Theodosi, G.-I., Makatounakis, T., …, & Kretsovali, A. (2017). Promyelocytic leukemia protein is an essential regulator of stem cell pluripotency and somatic cell reprogramming. Stem Cell Reports, 8(5), 1366–1378. https://doi.org/10.1016/j.stemcr.2017.03.006
Cheng, B., Ren, X., & Kerppola, T. K. (2014). KAP1 represses differentiation-inducible genes in embryonic stem cells through cooperative binding with PRC1 and derepresses pluripotency-associated genes. Molecular and Cellular Biology, 34(11), 2075–2091. https://doi.org/10.1128/MCB.01729-13
Oleksiewicz, U., Gładych, M., Raman, A. T., Heyn, H., Mereu, E., Chlebanowska, P., …, & Wiznerowicz, M. (2017). TRIM28 and interacting KRAB-ZNFs control self-renewal of human pluripotent stem cells through epigenetic repression of pro-differentiation genes. Stem Cell Reports, 9(6), 2065–2080. https://doi.org/10.1016/j.stemcr.2017.10.031
Hatakeyama, S. (2017). TRIM family proteins: Roles in autophagy, immunity, and carcinogenesis. Trends in Biochemical Sciences, 42(4), 297–311. https://doi.org/10.1016/j.tibs.2017.01.002
Sonoda, J., & Wharton, R. P. (2001). Drosophila brain tumor is a translational repressor. Genes & Development, 15(6), 762–773. https://doi.org/10.1101/gad.870801
Boulay, J.-L., Stiefel, U., Taylor, E., Dolder, B., Merlo, A., & Hirth, F. (2009). Loss of heterozygosity of TRIM3 in malignant gliomas. BMC Cancer, 9(1), 1–9. https://doi.org/10.1186/1471-2407-9-71
Chen, G., Kong, J., Tucker-Burden, C., Anand, M., Rong, Y., Rahman, F., …, & Brat, D. J. (2014). Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. Cancer Research, 74(16), 4536–4548. https://doi.org/10.1158/0008-5472.CAN-13-3703
Izumi, H., & Kaneko, Y. (2014). Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells. Cancer Research, 74(19), 5620–5630. https://doi.org/10.1158/0008-5472.CAN-14-0169
Wang, L., Bu, P., Ai, Y., Srinivasan, T., Chen, H. J., Xiang, K., …, & Shen, X. (2016). A long non-coding RNA targets microRNA miR-34a to regulate colon cancer stem cell asymmetric division. eLife, 5, e14620. https://doi.org/10.7554/eLife.14620
Zhang, Q., Wang, J., Li, N., Liu, Z., Chen, Z., Li, Z., …, & Gao, J. (2018). miR-34a increases the sensitivity of colorectal cancer cells to 5-fluorouracil in vitro and in vivo. American Journal of Cancer Research, 8(2), 280–290.
Hwang, W.-L., Jiang, J.-K., Yang, S.-H., Huang, T.-S., Lan, H.-Y., Teng, H.-W., …, & Yang, M.-H. (2014). MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nature Cell Biology, 16(3), 268–280. https://doi.org/10.1038/ncb2910
Yoshida, K., Yamamoto, Y., & Ochiya, T. (2021). miRNA signaling networks in cancer stem cells. Regenerative Therapy, 17, 1–7. https://doi.org/10.1016/j.reth.2021.01.004
Nwaeburu, C. C., Abukiwan, A., Zhao, Z., & Herr, I. (2017). Quercetin-induced miR-200b-3p regulates the mode of self-renewing divisions in pancreatic cancer. Molecular Cancer, 16(1), 23. https://doi.org/10.1186/s12943-017-0589-8
Huang, G., Wang, M., Li, X., Wu, J., Chen, S., Du, N., …, & Sun, X. (2019). TUSC7 suppression of Notch activation through sponging MiR-146 recapitulated the asymmetric cell division in lung adenocarcinoma stem cells. Life Sciences, 232, 116630. https://doi.org/10.1016/j.lfs.2019.116630
Ghanbari-Movahed, M., Ghanbari-Movahed, Z., Momtaz, S., Kilpatrick, K. L., Farzaei, M. H., & Bishayee, A. (2021). Unlocking the secrets of cancer stem cells with γ-secretase inhibitors: A novel anticancer strategy. Molecules, 26(4), 972. https://doi.org/10.3390/molecules26040972
Qiao, L., & Wong, B. C. Y. (2009). Role of Notch signaling in colorectal cancer. Carcinogenesis, 30(12), 1979–1986. https://doi.org/10.1093/carcin/bgp236
Stallings-Mann, M., Jamieson, L., Regala, R. P., Weems, C., Murray, N. R., & Fields, A. P. (2006). A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells. Cancer Research, 66(3), 1767–1774. https://doi.org/10.1158/0008-5472.CAN-05-3405
Chen, S., Zhao, Y., Peng, H., Liang, L., Li, Y., Hu, X., …, & Xu, Y. (2021). Polarity Protein Par3 Sensitizes Breast Cancer to Paclitaxel by Promoting Cell Cycle Arrest. (preprint). In Review. https://doi.org/10.21203/rs.3.rs-819518/v1
Schmoranzer, J., Fawcett, J. P., Segura, M., Tan, S., Vallee, R. B., Pawson, T., & Gundersen, G. G. (2009). Par3 and dynein associate to regulate local microtubule dynamics and centrosome orientation during migration. Current Biology, 19(13), 1065–1074. https://doi.org/10.1016/j.cub.2009.05.065
Tagal, V., & Roth, M. G. (2021). Loss of aurora kinase signaling allows lung cancer cells to adopt endoreplication and form polyploid giant cancer cells that resist antimitotic drugs. Cancer Research, 81(2), 400–413. https://doi.org/10.1158/0008-5472.CAN-20-1693
Lopez-Sánchez, L. M., Jimenez, C., Valverde, A., Hernandez, V., Peñarando, J., Martinez, A., …, & Rodriguez-Ariza, A. (2014). CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer. PLOS ONE, 9(6), e99143. https://doi.org/10.1371/journal.pone.0099143
Zhang, S., Zhang, D., Yang, Z., & Zhang, X. (2016). Tumor budding, micropapillary pattern, and polyploidy giant cancer cells in colorectal cancer: Current status and future prospects. Stem Cells International, 2016, e4810734. https://doi.org/10.1155/2016/4810734
Kim, H. J., & Kim, J. (2021). OTUD6A is an Aurora Kinase A-Specific Deubiquitinase. International Journal of Molecular Sciences, 22(4), 1936. https://doi.org/10.3390/ijms22041936
Asteriti, I. A., Cesare, E. D., Mattia, F. D., Hilsenstein, V., Neumann, B., Cundari, E., …, & Guarguaglini, G. (2014). The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidy. Oncotarget, 5(15), 6229–6242. https://doi.org/10.18632/oncotarget.2190
Liu, N., Hu, G., Wang, H., Li, Z., & Guo, Z. (2018). PLK1 inhibitor facilitates the suppressing effect of temozolomide on human brain glioma stem cells. Journal of Cellular and Molecular Medicine, 22(11), 5300–5310. https://doi.org/10.1111/jcmm.13793
Wang, X., Kuang, W., Ding, J., Li, J., Ji, M., Chen, W., …, & Yang, P. (2022). Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. Cancers, 14(15), 3629. https://doi.org/10.3390/cancers14153629
Auffinger, B., Tobias, A. L., Han, Y., Lee, G., Guo, D., Dey, M., …, & Ahmed, A. U. (2014). Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death and Differentiation, 21(7), 1119–1131. https://doi.org/10.1038/cdd.2014.31
Dey-Guha, I., Alves, C. P., Yeh, A. C., None, S., Sole, X., Darp, R., & Ramaswamy, S. (2015). A mechanism for asymmetric cell division resulting in proliferative asynchronicity. Molecular Cancer Research : MCR, 13(2). https://doi.org/10.1158/1541-7786.MCR-14-0474
Charnley, M., Ludford-Menting, M., Pham, K., & Russell, S. M. (2019). A new role for Notch in the control of polarity and asymmetric cell division of developing T cells. Journal of Cell Science, 133(5), jcs235358. https://doi.org/10.1242/jcs.235358
Wc, Y., Mm, F., F, A., C, B., J, C., B, C., …, & T, H. (2015). Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency. Clinical cancer research : an official journal of the American Association for Cancer Research, 21(9). https://doi.org/10.1158/1078-0432.CCR-14-2808
Hu, S., Fu, W., Li, T., Yuan, Q., Wang, F., Lv, G., …, & Lei, C. (2017). Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency. Science Translational Medicine, 9(380), eaag0339. https://doi.org/10.1126/scitranslmed.aag0339
Fu, W., Lei, C., Yu, Y., Liu, S., Li, T., Lin, F., …, & Hu, S. (2019). EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency. Clinical Cancer Research, 25(9), 2835–2847. https://doi.org/10.1158/1078-0432.CCR-18-2732
Munster, P., Eckhardt, S. G., Patnaik, A., Shields, A. F., Tolcher, A. W., Davis, S. L., …, & Ferrarotto, R. (2015). Abstract C42: Safety and preliminary efficacy results of a first-in-human phase I study of the novel cancer stem cell (CSC) targeting antibody brontictuzumab (OMP-52M51, anti-Notch1) administered intravenously to patients with certain advanced solid tumors. Molecular Cancer Therapeutics, 14(12_Supplement_2), C42. https://doi.org/10.1158/1535-7163.TARG-15-C42
Tanaka, S., Nakada, M., Yamada, D., Nakano, I., Todo, T., Ino, Y., …, & Hirao, A. (2015). Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells. Journal of Neuro-Oncology, 121(2), 239–250. https://doi.org/10.1007/s11060-014-1630-z
Du, F.-Y., Zhou, Q.-F., Sun, W.-J., & Chen, G.-L. (2019). Targeting cancer stem cells in drug discovery: Current state and future perspectives. World Journal of Stem Cells, 11(7), 398–420. https://doi.org/10.4252/wjsc.v11.i7.398
Issa, M. E., Berndt, S., Carpentier, G., Pezzuto, J. M., & Cuendet, M. (2016). Bruceantin inhibits multiple myeloma cancer stem cell proliferation. Cancer Biology & Therapy, 17(9), 966–975. https://doi.org/10.1080/15384047.2016.1210737
Liu, X., Wang, L., Cui, W., Yuan, X., Lin, L., Cao, Q., …, & Yang, J. (2016). Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells. Oncotarget, 7(36), 58516–58530. https://doi.org/10.18632/oncotarget.11305
Rodriguez-Torres, M., & Allan, A. L. (2016). Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors. Clinical & Experimental Metastasis, 33(1), 97–113. https://doi.org/10.1007/s10585-015-9755-9
Bernkopf, D. B., Daum, G., Brückner, M., & Behrens, J. (2018). Sulforaphane inhibits growth and blocks Wnt/β-catenin signaling of colorectal cancer cells. Oncotarget, 9(74), 33982–33994. https://doi.org/10.18632/oncotarget.26125
Galuppo, R., Maynard, E., Shah, M., Daily, M. F., Chen, C., Spear, B. T., & Gedaly, R. (2014). Synergistic inhibition of HCC and liver cancer stem cell proliferation by targeting RAS/RAF/MAPK and WNT/β-catenin pathways. Anticancer Research, 34(4), 1709–1713.
Liu, L., Zhi, Q., Shen, M., Gong, F.-R., Zhou, B. P., Lian, L., …, & Li, W. (2016). FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Oncotarget, 7(30), 47145–47162. https://doi.org/10.18632/oncotarget.9975
Lachenmayer, A., Alsinet, C., Savic, R., Cabellos, L., Toffanin, S., Hoshida, Y., …, & Llovet, J. M. (2012). Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 18(18), 4997–5007. https://doi.org/10.1158/1078-0432.CCR-11-2322
Rahmani, F., Amerizadeh, F., Hassanian, S. M., Hashemzehi, M., Nasiri, S.-N., Fiuji, H., …, & Avan, A. (2019). PNU-74654 enhances the antiproliferative effects of 5-FU in breast cancer and antagonizes thrombin-induced cell growth via the Wnt pathway. Journal of Cellular Physiology, 234(8), 14123–14132. https://doi.org/10.1002/jcp.28104
Wei, W., Chua, M.-S., Grepper, S., & So, S. (2010). Small molecule antagonists of Tcf4/β-catenin complex inhibit the growth of HCC cells in vitro and in vivo. International Journal of Cancer, 126(10), 2426–2436. https://doi.org/10.1002/ijc.24810
Fields, A. P., & Regala, R. P. (2007). Protein kinase C iota: Human oncogene, prognostic marker and therapeutic target. Pharmacological Research, 55(6), 487–497. https://doi.org/10.1016/j.phrs.2007.04.015
Wang, S., Cai, J., Zhang, S., Dong, M., Zhang, L., Xu, Y., …, & Chen, S. (2021). Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis. Cancer Science, 112(7), 2625–2641. https://doi.org/10.1111/cas.14920
Ohashi, S., Sakashita, G., Ban, R., Nagasawa, M., Matsuzaki, H., Murata, Y., …, & Urano, T. (2006). Phospho-regulation of human protein kinase Aurora-A: analysis using anti-phospho-Thr288 monoclonal antibodies. Oncogene, 25(59), 7691–7702. https://doi.org/10.1038/sj.onc.1209754
Manfredi, M. G., Ecsedy, J. A., Chakravarty, A., Silverman, L., Zhang, M., Hoar, K. M., …, & Sells, T. B. (2011). Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of aurora A kinase using novel in vivo pharmacodynamic assays. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 17(24), 7614–7624. https://doi.org/10.1158/1078-0432.CCR-11-1536
Lerner, R. G., Grossauer, S., Kadkhodaei, B., Meyers, I., Sidorov, M., Koeck, K., …, & Petritsch, C. K. (2015). Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells. Cancer Research, 75(24), 5355–5366. https://doi.org/10.1158/0008-5472.CAN-14-3689
Wang, R., & Liu, C. (2019). All-trans retinoic acid therapy induces asymmetric division of glioma stem cells from the U87MG cell line. Oncology Letters, 18(4), 3646–3654. https://doi.org/10.3892/ol.2019.10691
Tallman, M. S., Andersen, J. W., Schiffer, C. A., Appelbaum, F. R., Feusner, J. H., Ogden, A., …, & Wiernik, P. H. (1997). All-trans-Retinoic Acid in Acute Promyelocytic Leukemia. New England Journal of Medicine, 337(15), 1021–1028. https://doi.org/10.1056/NEJM199710093371501
Qian, Y., Shi, L., & Luo, Z. (2020). Long non-coding RNAs in cancer: Implications for diagnosis, prognosis, and therapy. Frontiers in Medicine, 7, 612393. https://doi.org/10.3389/fmed.2020.612393
Gibellini, L., Pinti, M., Nasi, M., Montagna, J. P., De Biasi, S., Roat, E., …, & Cossarizza, A. (2011). Quercetin and Cancer Chemoprevention. Evidence-Based Complementary and Alternative Medicine, 2011, 1–15. https://doi.org/10.1093/ecam/neq053
Zahavi, D., & Weiner, L. (2020). Monoclonal antibodies in cancer therapy. Antibodies, 9(3), 34. https://doi.org/10.3390/antib9030034
Hajirasouliha, I., Mahmoody, A., & Raphael, B. J. (2014). A combinatorial approach for analyzing intra-tumor heterogeneity from high-throughput sequencing data. Bioinformatics, 30(12), i78–i86. https://doi.org/10.1093/bioinformatics/btu284
Marjanovic, N. D., Hofree, M., Chan, J. E., Canner, D., Wu, K., Trakala, M., …, & Tammela, T. (2020). Emergence of a High-Plasticity Cell State during Lung Cancer Evolution. Cancer Cell, 38(2), 229–246.e13. https://doi.org/10.1016/j.ccell.2020.06.012
Wooten, M., Ranjan, R., & Chen, X. (2020). Asymmetric histone inheritance in asymmetrically dividing stem cells. Trends in Genetics, 36(1), 30–43. https://doi.org/10.1016/j.tig.2019.10.004
Zion, E. H., Chandrasekhara, C., & Chen, X. (2020). Asymmetric inheritance of epigenetic states in asymmetrically dividing stem cells. Current Opinion in Cell Biology, 67, 27–36. https://doi.org/10.1016/j.ceb.2020.08.003
Zion, E., & Chen, X. (2021). Breaking symmetry: The asymmetries in epigenetic inheritance. The Biochemist, 43(1), 14–19. https://doi.org/10.1042/bio_2020_110
French, R., & Pauklin, S. (2021). Epigenetic regulation of cancer stem cell formation and maintenance. International Journal of Cancer, 148(12), 2884–2897. https://doi.org/10.1002/ijc.33398
Suzuki, A., Yamanaka, T., Hirose, T., Manabe, N., Mizuno, K., Shimizu, M., …, & Ohno, S. (2001). Atypical Protein Kinase C Is Involved in the Evolutionarily Conserved Par Protein Complex and Plays a Critical Role in Establishing Epithelia-Specific Junctional Structures. Journal of Cell Biology, 152(6), 1183–1196. https://doi.org/10.1083/jcb.152.6.1183
Wu, M.-J., Chen, Y.-S., Kim, M. R., Chang, C.-C., Gampala, S., Zhang, Y., …, & Chang, C.-J. (2019). Epithelial-Mesenchymal Transition Directs Stem Cell Polarity via Regulation of Mitofusin. Cell Metabolism, 29(4), 993–1002.e6. https://doi.org/10.1016/j.cmet.2018.11.004
Acknowledgements
We acknowledge Ms. Sucheta Mondal for her help in writing this review. We are also thankful to Dr. Jayanta Chakraborty, Director, Chittaranjan National Cancer Institute.
Funding
This work was supported by SERB sponsored projects (EEQ/2020/000601 and CRG/2021/007813). We wish to acknowledge the funding organization CSIR for their financial support.
Author information
Authors and Affiliations
Contributions
Conceptualization: P.SM and A.B; literature search and data analysis: P.SM and A.B, Writing—original draft preparation: P.SM, A.B, S.B, R.S, R.G, S.P, M.M, S.S, P.S and S.H; Writing—review and editing: S.B, R.S, R.G, S.P, M.M, S.S, P.S and S.H; Funding acquisition: P.S and S.H.
Corresponding authors
Ethics declarations
Ethical Approval
Not Applicable
Consent to Participate
Not Applicable
Consent to Publish
Not Applicable
Competing Interests
The authors confirm that this article content has no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Samanta, P., Bhowmik, A., Biswas, S. et al. Therapeutic Effectiveness of Anticancer Agents Targeting Different Signaling Molecules Involved in Asymmetric Division of Cancer Stem Cell. Stem Cell Rev and Rep 19, 1283–1306 (2023). https://doi.org/10.1007/s12015-023-10523-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-023-10523-3